MENU
THTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Theratechnologies (THTX) Ownership - Who owns Theratechnologies?

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients... Show more

Profile

Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
146.35M
P/E Ratio
N/A
Total Cash
9.92M
Projected Growth
N/A
Total Debt
43.62M
Revenue
84.38M
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
1.71 USD as % of share price

Fundamentals

THTX
Capitalization
146M
P/E Ratio
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash
9.92M
Total Cash/Share
0.22
Total Debt
43.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.71%
Revenue
84.4M
ROE
N/A
Book Value
-27.92M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
364M
Current Ratio
0.84
Current Revenue Per Employee
168847.62
Dividends Per Share - Security
N/A
EBITDA
2.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
73.50
Revenue To Assets
-15.08
Shares Held By Institutions
18.2M
Shares Outstanding - Current
46M
Total Liabilities
79.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
75.138
View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com